GlassScriptPhysician profile
Kavitha V Manjunath
NPI 1992847768
$9,131.87
in general payments reported to CMS, 2019-2025
47 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,525 · 2020: $785 · 2021: $1,068 · 2022: $1,522 · 2023: $2,095 · 2024: $733 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,040 · Travel and Lodging: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,039.67 |
| Travel and Lodging | $191.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,965.06 | 2019-2024 | |
| Glaxosmithkline, LLC. | $750.54 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $706.02 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $686.39 | 2019-2024 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $621.24 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $572.75 | 2019-2024 | Farxiga |
| Pfizer INC. | $429.69 | 2019-2024 | |
| Boston Scientific Corporation | $418.55 | 2019-2025 | Watchman Flx, Watchman |
| Merck Sharp & Dohme LLC | $303.93 | 2019-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Amarin Pharma, INC. | $276.33 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $264.75 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.49 | 2019-2024 | Jardiance |
| Allergan, INC. | $201.17 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $186.95 | 2019 | |
| Daiichi Sankyo INC. | $164.80 | 2021-2023 | Injectafer |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavitha Manjunath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.